The Global Vitamin K3 (Menadione)Market, valued at USD 8.8 Billion in 2023, growing at a CAGR of 5.93% during the forecast period 2024-2032. Vitamin K3, also known as menadione, is a synthetic form of vitamin K that plays a vital role in various physiological processes such as blood clotting and bone health in both humans and animals. Vitamin K3 (Menadione)is widely used in dietary supplements, pharmaceuticals, and animal feed due to its critical role in promoting health and preventing deficiencies.
The growing awareness about the health benefits of Vitamin K3, its incorporation in animal feed, and its use in pharmaceutical and cosmetic industries are driving market growth. The increasing demand for dietary supplements, especially among the elderly population and individuals with bone-related disorders such as osteoporosis, is contributing to the rising demand for Vitamin K3-based products. Furthermore, its use in cosmetics, particularly in anti-aging and skin health formulations, is fueling market expansion. The increasing use of Vitamin K3 (Menadione)in animal feed to improve livestock health and productivity is also a significant factor propelling the market forward.
North America leads the global Vitamin K3 (Menadione)market due to high health awareness, increased supplement consumption, and the demand for livestock nutrition products. The Asia-Pacific region is expected to grow at a rapid pace, driven by rising disposable incomes, growing awareness of health and wellness, and the expanding pharmaceutical and animal feed industries.
Major players in the market includes:
DSM Nutritional Products
BASF SE
Adisseo
Zhejiang NHU Co., Ltd.
Shandong Huasheng Chemical Co., Ltd.
Mianyang Vanetta Chemical Co., Ltd.
Brother Enterprises Holding Co., Ltd.
Jiangsu Yiming Biological Technology Co., Ltd.
Huvepharma
Changzhou Highassay Chemical Co., Ltd.
Nantong Acetic Acid Chemical Co., Ltd.
Chengdu Chelation Biology Technology Co., Ltd.
Hubei Marvel-Bio Pharmaceutical Co., Ltd.
Xiamen Hisunny Chemical Co., Ltd.
Tianjin Zhongrui Pharmaceutical Co., Ltd.
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of MEA
Years considered for the study:
Historical year - 2018-2023
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand-side and supply-side analysis of the market.